Delivery Order 36F79720D0136-36C24824N0187
Award Date
11/2/23
Potential Completion Date
11/2/23
Potential Value
$275K
Federal Agency
Veterans Integrated Service Network 8
Awardee
Ferring Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration awarded a delivery order contract to Ferring Pharmaceuticals Inc., a for-profit manufacturer, to provide the oncology medication Adstiladrin (nadofaragene firadenovec) under the agency's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The $45,829.15 firm-fixed price order is for delivery by December 31, 2024 to support the VA's provision of healthcare services to veterans through its integrated network of...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $194,860.32 delivery order to Urogen Pharma Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract. The firm fixed price order is for the delivery of JELMYTO mitomycin and has an anticipated completion date of August 9, 2023. Placement on the Pharmaceuticals and Drugs FSS vehicle establishes pre-negotiated pricing terms for ordering agencies like the VA to...
The Department of Veterans Affairs (VA) awarded a $2,425.46 firm-fixed price delivery order to Vifor (International) AG, a global biotechnology company and manufacturer, to provide the pharmaceutical product Korsuva (difelikefalin) to VA facilities. This order was placed against Vifor's Federal Supply Schedule contract for Pharmaceuticals and Drugs. The delivery order has a completion date of May 8, 2024 and was awarded on April 23, 2024 without any set-aside designation. Vifor has previously...
This is a $131,180 firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit organization. The contract is for the RA-223 (Xofigo) treatment for cancer patients, which is a specialized radiopharmaceutical product. The award is under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, which allows various federal agencies to place delivery orders for a broad range of...
This is a delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Astellas Pharma US, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the oncology drug XTANDI under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS) contract. The delivery order has a firm fixed price of $243,162.00 and an ultimate completion date of December 30, 2016. This order was placed under a larger $3.5 billion FSS contract awarded by the VA in...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded a $15,090.62 delivery order to Janssen Biotech, Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) for the drug erdafitinib. The firm fixed price order is for delivery to a location in Horsham, Pennsylvania, with completion by September 30, 2021. No set aside designation was used for this order to support VHA programs. Janssen Biotech will provide...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,090.88 delivery order to Janssen Biotech, Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) for BALVERSA 4 MG. The firm fixed price order is for the delivery of the specified pharmaceutical product to a location in Carrollton, Texas, with performance to be completed by November 13, 2020. No set-aside designation was applied to this order placed...
This $200,163.52 delivery order was awarded to Actelion Pharmaceuticals US, Inc., a for-profit manufacturer of specialty pharmaceutical products, by the Department of Veterans Affairs (VA) Veterans Health Administration. The order was placed against Actelion's existing five-year, $105 million Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which allows federal agencies to procure pre-negotiated prescription medications. The contract does not have a set-aside...
This is a $351,244.44 firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Actelion Pharmaceuticals US, Inc., a large pharmaceutical manufacturer. The order is for specialty medication, primarily treatments for pulmonary arterial hypertension, which are critical drugs for VA medical centers and other federal healthcare facilities. The contract is placed against Actelion's $105 million Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $2,425.46 firm-fixed-price delivery order to Vifor (International) AG, a foreign-owned for-profit pharmaceutical manufacturer, to provide the emergency medication KORSUVA (difelikefalin) to VHA's Veterans Integrated Service Network 21. This delivery order was placed against Vifor's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The order has a performance period through May...